Personalised medicine

Photo

News • Concerns about hurried adoption

Survey: Is medical AI taking over too quickly?

The pace of artificial intelligence (AI) adoption in personalised medicine is unsettling for great parts of the public. A new survey reflects the worried state of mind in the UK.

Photo

News • Diffuse Large B-Cell Lymphoma (DLBCL)

Personalised simulations predict outcomes for blood cancer treatment

Using genomic sequencing data, researchers have created personalised simulations of individual patients that can quantify the impact of genetic mutations on cancer cell behaviour.

Photo

News • New technology approach

‘Personalised’ hip replacements to improve outcomes

Using advanced technology from the automotive and manufacturing industries, researchers are driving medical advancement to create ‘personalised’ hip replacements.

Photo

News • Multimaterial medication

New 3D printing research for personalised pills

Researchers have developed a cutting-edge method for fabrication of customised pharmaceutical tablets with tailored drug release profiles, ensuring more precise and effective treatment options.

Photo

News • GMAI for cancer treatment

Generalist Medical AI: Experts propose legal guardrails

Generalist Medical Artificial Intelligence (GMAI) models pose a significant challenge to current regulatory frameworks. Experts discuss how regulation of these models could work in the future.

Photo

News • New-found blood signatures

Multiple sclerosis: subtype discovery opens new ways for personalized therapy

Researchers discovered three distinct immunological endophenotypes of multiple sclerosis, defined by specific blood immune signatures. This opens new avenues for personalized treatment strategies.

Photo

Article • Progress, limitations, and opportunities

Precision oncology: incredible potential, but not a miracle cure

Unanswered questions are hampering clinicians in their efforts to get the best out of a precision medicine approach for their patients. Speaking at the Genomics and Precision Medicine Expo in London at the end of May, cancer educator Dr Elaine Vickers said the benefits of being matched to an investigational drug remain questionable for most people with advanced cancer.

Photo

Article • Patient-specific parameters in ionizing radiation usage

A more tailored approach to dose reduction

Radiation exposure in diagnostic and interventional radiology is steadily being reduced, but some important parameters have hardly been taken into account so far, says Dr Kerstin Jungnickel. The medical physics expert explains how patient-specific protocols can improve radiation protection and outlined new findings on the radiosensitivity of certain body regions and their impact.

Photo

Article • Inks and polymers

3D printed pharmaceuticals for personalized therapies

60 percent of all administered drugs do not have the desired therapeutic effect. Even worse: in Germany alone about 60,000 deaths per year are caused by medication. With these shocking statistics Professor Dr Christian Franken started his presentation on “Pills from the 3D printer” at last year’s Medica in Düsseldorf. He hopes that his vision of personalized medication based on 2D and 3D…

Photo

Article • Tissue-engineered glioblastoma model

3D brain tumour in a dish to personalize cancer treatment

It is the size of a common pencil eraser, but it could have a huge impact on the therapy of glioblastoma: Scientists in Virginia have developed a novel 3D tissue-engineered model of the brain tumour microenvironment, which can be used to assess how the glioma cell invades healthy tissue, proliferates, and reacts to chemotherapy drugs.

212 show more articles
Subscribe to Newsletter